News

Stay informed on the latest clinical milestones, media coverage, and partnerships from J3 Bioscience.

Explore how our IVR platform continues to drive new opportunities for hormone-free innovation in women’s health.

Madelyn De Los Santos 11/10/25 Madelyn De Los Santos 11/10/25

J3 Bioscience Announces Collaboration to Study LIV-Ring VR101 for Cancer-Therapy–Related Vaginal Dryness

Madelyn De Los Santos 8/4/25 Madelyn De Los Santos 8/4/25

J3 Bioscience appoints Qun Xu as head of finance to support growth and drive visibility for women’s health innovation

Madelyn De Los Santos 6/24/25 Madelyn De Los Santos 6/24/25

J3 Bioscience appoints Dr. Stephanie Singer as medical director

Madelyn De Los Santos 6/5/25 Madelyn De Los Santos 6/5/25

Consumers find LIV-Ring effectively addresses needs for vaginal dryness relief.

The findings demonstrate the effectiveness of LIV-Ring in addressing symptoms commonly associated with vaginal dryness – the second most common symptom of menopause – offering a meaningful new option to women seeking clinically tested, non-hormonal, and readily accessible solutions.

Madelyn De Los Santos 4/3/25 Madelyn De Los Santos 4/3/25

J3 Bioscience, Inc. appoints John Fair as new president & CEO.

J3 Bioscience, Inc., a commercialization stage startup medical device company focused on women’s health, today announced the appointment of John Fair as its new President and Chief Executive Officer, effective immediately. Founder and current CEO Tyler McCabe will transition to the role of Chief Operating Officer.

Emilie Maritnez 10/1/24 Emilie Maritnez 10/1/24

J3 Bioscience, Inc. announces appointment of new director to board

J3 Bioscience, Inc., a commercialization stage women’s health medical device company, today announced the appointment of Dr. Sheryl A. Kingsberg to its Board of Directors.